Literature DB >> 8061860

Extracellular matrix-degrading proteinases in the nervous system.

A M Romanic1, J A Madri.   

Abstract

The proteolytic activities of matrix metalloproteinases and plasminogen activators as well as their inhibitors are important in maintaining the integrity of the extracellular matrix (ECM). Cell-ECM interactions influence cell proliferation, differentiation, adhesion and migration. In the nervous system, proteolysis of the ECM is involved in neuronal cell migration in the developing cerebellum and in neurite outgrowth. Likewise, in pathological conditions such as brain tumour growth and invasion, leukocyte infiltration into brain tumours, leukocyte trafficking in the central nervous system in inflammatory diseases such as multiple sclerosis and viral encephalitis, and in nerve demyelination, matrix-degrading proteinases and their inhibitors have been implicated. An understanding of cell-ECM interactions and ECM degradation in diseases of the nervous system would provide new insight for drug design and other forms of therapy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8061860     DOI: 10.1111/j.1750-3639.1994.tb00825.x

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  37 in total

Review 1.  Extracellular matrix degradation by metalloproteinases and central nervous system diseases.

Authors:  A Lukes; S Mun-Bryce; M Lukes; G A Rosenberg
Journal:  Mol Neurobiol       Date:  1999-06       Impact factor: 5.590

2.  Cauda equina-derived extracellular matrix for fabrication of nanostructured hybrid scaffolds applied to neural tissue engineering.

Authors:  Xiaoxiao Wen; Yu Wang; Zhiyuan Guo; Haoye Meng; Jingxiang Huang; Li Zhang; Bin Zhao; Qing Zhao; Yudong Zheng; Jiang Peng
Journal:  Tissue Eng Part A       Date:  2014-12-16       Impact factor: 3.845

3.  Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.

Authors:  S Wagner; C Stegen; H Bouterfa; C Huettner; S Kerkau; W Roggendorf; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  1998-11       Impact factor: 4.130

4.  Medulloblastoma displays distinct regional matrix metalloprotease expression.

Authors:  G H Vince; C Herbold; R Klein; J Kühl; T Pietsch; S Franz; K Roosen; J C Tonn
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 5.  Membrane-type matrix metalloproteinases (MT-MMPs): expression and function during glioma invasion.

Authors:  H L Fillmore; T E VanMeter; W C Broaddus
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

Review 6.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

7.  Neuroserpin is expressed in the pituitary and adrenal glands and induces the extension of neurite-like processes in AtT-20 cells.

Authors:  R M Hill; P K Parmar; L C Coates; E Mezey; J F Pearson; N P Birch
Journal:  Biochem J       Date:  2000-02-01       Impact factor: 3.857

8.  Mononuclear phagocyte differentiation, activation, and viral infection regulate matrix metalloproteinase expression: implications for human immunodeficiency virus type 1-associated dementia.

Authors:  A Ghorpade; R Persidskaia; R Suryadevara; M Che; X J Liu; Y Persidsky; H E Gendelman
Journal:  J Virol       Date:  2001-07       Impact factor: 5.103

9.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

10.  Cerebrospinal fluid activity of tissue plasminogen activator in patients with neurological diseases.

Authors:  F O Akenami; V Sirén; M Koskiniemi; M A Siimes; H Teräväinen; A Vaheri
Journal:  J Clin Pathol       Date:  1996-07       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.